News

GreenLight hands pink slips to 96 people in Massachusetts as halving of headcount begins
ntaylor
Thu, 06/08/2023 – 10:00 Click here to view original post… […]

A biotech startup chaired by Vertex Pharmaceuticals founder and former CEO Josh Boger has raised $150 million, plus other life sciences news you might have missed. Click here to view original post… […]

FRAMINGHAM, Mass. & GREATER NAPANEE, Ontario–(BUSINESS WIRE)– #carbonreduction–Ameresco and Atura Power JV selected to build 250MW/1,000MWh battery energy storage system. Click here to view original post… […]

FDA Commissioner Robert Califf told a crowd of biotech leaders at the BIO convention that drug costs needed fixing. Click here to view original post… […]

Investors are waiting to see if upcoming approvals and launches will reinvigorate the gene therapy sector and showing whether such drugs can generate a return on investment. Click here to view original post… […]

WALTHAM, Mass.–(BUSINESS WIRE)–Upstream Bio announces $200 million Series B financing to support the development of UPB-101 in asthma and CRSwNP. Click here to view original post… […]

Upstream Bio has raised another $200 million to go through Phase II studies and prepare for late-stage trials of an ex-Astellas monoclonal antibody in anticipation of competition with AstraZeneca and Amgen’s asthma drug Tezspire. The raise, disclosed Thursday morning, mirrors its first funding round from 2021 and will bankroll… Click here to view original post… […]

“Great science, great IP, great CEO, great people.” Here are three takeaways from a discussion between three MIT entrepreneurs on what makes a successful biotech startup. Click here to view original post… […]

HPC analysts say that between 2000 and 2021, the premium payments Mass. employees must make for their workplace-sponsored health insurance plans grew by 295%. Click here to view original post… […]

Shortages put a drug needed for heart surgery out of reach — so Tufts is making cardioplegia itself. Click here to view original post… […]